Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 4, 2025
CXCL14
is
a
highly
conserved
chemokine
expressed
in
various
cell
types,
playing
crucial
roles
both
physiological
and
pathological
processes,
including
immune
regulation
tumorigenesis.
Recently,
the
role
of
tumors
has
attracted
considerable
attention.
However,
previous
pan-cancer
studies
have
reported
inconsistencies
regarding
effects
on
tumors,
particularly
concerning
its
expression
levels
tumor
tissues
influence
phenotypes
cancer
cells.
This
variability
believed
to
stem
from
context-dependent
nature
CXCL14,
as
different
sources
secretion
within
distinct
microenvironments
may
mediate
diverse
biological
effects.
Such
phenomena
also
been
observed
prostate
research.
Despite
foundational
understanding
cancer,
there
remains
lack
comprehensive
reviews
summarizing
specific
this
systematically
analyzing
reasons
behind
complex
Therefore,
article
aims
discuss
microenvironment
explore
future
research
directions
potential
applications.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
35(51)
Published: May 17, 2023
Abstract
Messenger
RNA
(mRNA)
has
received
great
attention
in
the
prevention
and
treatment
of
various
diseases
due
to
success
coronavirus
disease
2019
(COVID‐19)
mRNA
vaccines
(Comirnaty
Spikevax).
To
meet
therapeutic
purpose,
it
is
required
that
must
enter
target
cells
express
sufficient
proteins.
Therefore,
development
effective
delivery
systems
necessary
crucial.
Lipid
nanoparticle
(LNP)
represents
a
remarkable
vehicle
indeed
accelerated
applications
humans,
as
several
mRNA‐based
therapies
have
already
been
approved
or
are
clinical
trials.
In
this
review,
focus
on
mRNA‐LNP‐mediated
anticancer
therapy.
It
summarizes
main
strategies
mRNA‐LNP
formulations,
discusses
representative
approaches
cancer,
points
out
current
challenges
possible
future
directions
research
field.
hoped
these
delivered
messages
can
help
further
improve
application
technology
cancer
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Jan. 9, 2024
Abstract
The
CRISPR
system
is
a
revolutionary
genome
editing
tool
that
has
the
potential
to
revolutionize
field
of
cancer
research
and
therapy.
ability
precisely
target
edit
specific
genetic
mutations
drive
growth
spread
tumors
opened
up
new
possibilities
for
development
more
effective
personalized
treatments.
In
this
review,
we
will
discuss
different
CRISPR-based
strategies
have
been
proposed
therapy,
including
inactivating
genes
tumor
growth,
enhancing
immune
response
cells,
repairing
cause
cancer,
delivering
cancer-killing
molecules
directly
cells.
We
also
summarize
current
state
preclinical
studies
clinical
trials
highlighting
most
promising
results
challenges
still
need
be
overcome.
Safety
delivery
are
important
therapy
become
viable
option.
limitations
overcome,
such
as
off-target
effects,
safety,
site.
Finally,
provide
an
overview
opportunities
in
future
directions
development.
change
landscape
research,
review
aims
overcome
realize
potential.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Aug. 7, 2024
Multicellular
organisms
are
composed
of
diverse
cell
types
that
must
coordinate
their
behaviors
through
communication.
Cell-cell
communication
(CCC)
is
essential
for
growth,
development,
differentiation,
tissue
and
organ
formation,
maintenance,
physiological
regulation.
Cells
communicate
direct
contact
or
at
a
distance
using
ligand-receptor
interactions.
So
cellular
encompasses
two
processes:
signal
conduction
generation
intercellular
transmission
signals,
transduction
reception
procession
signals.
Deciphering
networks
critical
understanding
metabolism.
First,
we
comprehensively
review
the
historical
milestones
in
CCC
studies,
followed
by
detailed
description
mechanisms
molecule
importance
main
signaling
pathways
they
mediate
maintaining
biological
functions.
Then
systematically
introduce
series
human
diseases
caused
abnormalities
progress
clinical
applications.
Finally,
summarize
various
methods
monitoring
interactions,
including
imaging,
proximity-based
chemical
labeling,
mechanical
force
analysis,
downstream
analysis
strategies,
single-cell
technologies.
These
aim
to
illustrate
how
functions
depend
on
these
interactions
complexity
regulatory
regulate
crucial
processes,
homeostasis,
immune
responses
diseases.
In
addition,
this
enhances
our
processes
occur
after
cell-cell
binding,
highlighting
its
application
discovering
new
therapeutic
targets
biomarkers
related
precision
medicine.
This
collective
provides
foundation
developing
targeted
drugs
personalized
treatments.
Journal of Drug Delivery Science and Technology,
Journal Year:
2024,
Volume and Issue:
92, P. 105338 - 105338
Published: Jan. 6, 2024
The
rapid
advancement
of
CRISPR-Cas9
technology
has
instigated
a
profound
transformation
in
genome
editing
with
significant
implications
for
fields
like
health,
agriculture,
and
biotechnology.
This
abstract
provides
an
overview
the
historical
significance
fundamental
components
CRISPR-Cas9,
notably
Cas9
protein
guide
RNA,
underscoring
its
pivotal
role
genetic
manipulation.
It
emphasizes
CRISPR-Cas9's
preeminence
domain
precise
editing,
driving
breakthroughs
personalized
medicine,
gene
therapy,
agriculture.
Of
paramount
importance
is
integration
nanomaterials,
encompassing
lipid-based
polymeric
nanoparticles,
alongside
viral
vectors,
serving
as
potent
vehicles
augmenting
delivery
efficiency
precision.
We
explore
strategies
aimed
at
enhancing
through
while
also
addressing
ethical
regulatory
considerations.
In
expert
opinion
section,
we
offer
nuanced
perspective
on
present
state
field,
highlighting
potential
transformative
progress
research
therapy.
stands
brink
unlocking
new
possibilities
providing
innovative
solutions
to
address
pressing
global
challenges.
MedComm – Oncology,
Journal Year:
2024,
Volume and Issue:
3(1)
Published: March 1, 2024
Abstract
Rapid
growth
in
nanoparticles
(NPs)
as
delivery
systems
holds
vast
promise
to
promote
therapeutic
approaches
for
cancer
treatment.
Presently,
a
diverse
array
of
NPs
with
unique
properties
have
been
developed
overcome
different
challenges
and
achieve
sophisticated
routes
enhancement
series
therapies.
Inspiring
advances
achieved
the
field
therapy
using
NPs.
In
this
review,
we
aim
summarize
up‐to‐date
progression
addressing
various
challenges,
expect
elicit
novel
potential
opportunities
alternatively.
We
first
introduce
sorts
NP
technologies,
illustrate
their
mechanisms,
present
applications.
Then,
achievements
made
by
break
obstacles
delivering
cargoes
specific
sites
through
particular
are
highlighted,
including
long‐circulation,
tumor
targeting,
responsive
release,
subcellular
localization.
subsequently
retrospect
recent
research
treatments
from
single
therapy,
like
chemotherapy,
combination
chemoradiotherapy,
integrative
therapy.
Finally,
perspectives
impact
on
oncology
discussed.
believe
review
can
offer
deeper
understanding
Molecular Cancer,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: Aug. 30, 2024
Drug
resistance
in
cancer
cells
significantly
diminishes
treatment
efficacy,
leading
to
recurrence
and
metastasis.
A
critical
factor
contributing
this
is
the
epigenetic
alteration
of
gene
expression
via
RNA
modifications,
such
as
N6-methyladenosine
(m6A),
N1-methyladenosine
(m1A),
5-methylcytosine
(m5C),
7-methylguanosine
(m7G),
pseudouridine
(Ψ),
adenosine-to-inosine
(A-to-I)
editing.
These
modifications
are
pivotal
regulating
splicing,
translation,
transport,
degradation,
stability.
Governed
by
"writers,"
"readers,"
"erasers,"
impact
numerous
biological
processes
progression,
including
cell
proliferation,
stemness,
autophagy,
invasion,
apoptosis.
Aberrant
can
lead
drug
adverse
outcomes
various
cancers.
Thus,
targeting
modification
regulators
offers
a
promising
strategy
for
overcoming
enhancing
efficacy.
This
review
consolidates
recent
research
on
role
prevalent
resistance,
with
focus
m6A,
m1A,
m5C,
m7G,
Ψ,
A-to-I
Additionally,
it
examines
regulatory
mechanisms
linked
underscores
existing
limitations
field.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
15
Published: Jan. 9, 2025
Despite
enormous
progress,
advanced
cancers
are
still
one
of
the
most
serious
medical
problems
in
current
society.
Although
various
agents
and
therapeutic
strategies
with
anticancer
activity
known
used,
they
often
fail
to
achieve
satisfactory
long-term
patient
outcomes
survival.
Recently,
immunotherapy
has
shown
success
patients
by
harnessing
important
interactions
between
immune
system
cancer.
However,
many
these
therapies
lead
frequent
side
effects
when
administered
systemically,
prompting
treatment
modifications
or
discontinuation
or,
severe
cases,
fatalities.
New
approaches
like
intratumoral
immunotherapy,
characterized
reduced
effects,
cost,
systemic
toxicity,
offer
promising
prospects
for
future
applications
clinical
oncology.
In
context
locally
metastatic
cancer,
combining
diverse
immunotherapeutic
other
targeting
multiple
cancer
hallmarks
appears
crucial.
Such
combination
hold
promise
improving
survival
promoting
a
sustained
response.
This
review
aims
provide
overview
approaches,
specifically
focusing
on
administration
drugs
cancers.
It
also
explores
integration
modalities
maximize
Additionally,
summarizes
recent
advances
discusses
novel
outlining
directions
field.
Signal Transduction and Targeted Therapy,
Journal Year:
2022,
Volume and Issue:
7(1)
Published: Oct. 2, 2022
Abstract
Extrachromosomal
circular
DNA
(eccDNA),
ranging
in
size
from
tens
to
millions
of
base
pairs,
is
independent
conventional
chromosomes.
Recently,
eccDNAs
have
been
considered
an
unanticipated
major
source
somatic
rearrangements,
contributing
genomic
remodeling
through
chimeric
circularization
and
reintegration
into
the
linear
genome.
In
addition,
origin
eccDNA
be
associated
with
essential
chromatin-related
events,
including
formation
super-enhancers
repair
machineries.
Moreover,
our
understanding
properties
functions
has
continuously
greatly
expanded.
Emerging
investigations
demonstrate
that
serve
as
multifunctional
molecules
various
organisms
during
diversified
biological
processes,
such
epigenetic
remodeling,
telomere
trimming,
regulation
canonical
signaling
pathways.
Importantly,
its
special
distribution
potentiates
a
measurable
biomarker
many
diseases,
especially
cancers.
The
loss
homeostasis
facilitates
tumor
initiation,
malignant
progression,
heterogeneous
evolution
An
in-depth
provides
novel
insights
for
precision
cancer
treatment.
this
review,
we
summarized
discovery
history
eccDNA,
discussed
biogenesis,
characteristics,
eccDNA.
emphasized
role
pathogenesis
evolution.
Therapeutically,
potential
clinical
applications
target
aberrant
multiple
diseases.
International Journal of Nanomedicine,
Journal Year:
2023,
Volume and Issue:
Volume 18, P. 1433 - 1468
Published: March 1, 2023
Abstract:
With
the
booming
development
of
nanomedicine,
mild
photothermal
therapy
(mPTT,
42–
45°C)
has
exhibited
promising
potential
in
tumor
therapy.
Compared
with
traditional
PTT
(>
50°C),
mPTT
less
side
effects
and
better
biological
conducive
to
treatment,
such
as
loosening
dense
structure
tissues,
enhancing
blood
perfusion,
improving
immunosuppressive
microenvironment.
However,
a
relatively
low
temperature
cannot
allow
completely
eradicate
tumors,
therefore,
substantial
efforts
have
been
conducted
optimize
application
This
review
extensively
summarizes
latest
advances
mPTT,
including
two
sections:
(1)
taking
leading
role
maximize
its
effect
by
blocking
cell
defense
mechanisms,
(2)
regarding
supporting
assist
other
therapies
achieve
synergistic
antitumor
curative
effect.
Meanwhile,
special
characteristics
imaging
capabilities
nanoplatforms
applied
various
are
discussed.
At
last,
this
paper
puts
forward
bottlenecks
challenges
current
research
path
possible
solutions
directions
future
proposed
correspondingly.
Keywords:
nanotechnology,
therapy,
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(19), P. 14865 - 14865
Published: Oct. 3, 2023
CRISPR/Cas9-mediated
cleavage
of
DNA,
which
depends
on
the
endonuclease
activity
Cas9,
has
been
widely
used
for
gene
editing
due
to
its
excellent
programmability
and
specificity.
However,
changes
DNA
sequence
that
are
mediated
by
CRISPR/Cas9
affect
structures
stability
genome,
may
accuracy
results.
Mutations
in
RuvC
HNH
regions
Cas9
protein
lead
inactivation
into
dCas9
with
no
activity.
Despite
loss
activity,
can
still
bind
strand
using
guide
RNA.
Recently,
proteins
active/inhibitory
effects
have
linked
end
form
fusion
transcriptional
effects,
named
CRISPRa
CRISPRi,
respectively.
These
CRISPR
tools
mediate
transcription
protein-coding
non-coding
genes
regulating
chromosomal
modification
states
target
promoters,
enhancers,
other
functional
elements.
Here,
we
highlight
epigenetic
mechanisms
applications
common
CRISPR/dCas9
tools,
hope
provide
a
reference
future
related
regulation,
function,
high-throughput
screening,
disease
treatment.